Virus based Therapies – from Molecules to Therapeutic Approaches
Stadthaus Ulm
November 29, 2024
3rd Joint Meeting of GBM & BioPharma Cluster South Germany
Welcome
Dear colleagues and friends,
The successful series of joint events between the BioPharma Cluster South Germany and the German Society for Biochemistry and Molecular Biology (GBM) continues.
In 2024, we will focus on Virus based Therapies, highlighting and discussing the status, future opportunities and challenges of these novel promising therapeutic approaches, particularly in the light of the novel National Strategy for Gene and Cell Therapies.
The event will cover various aspects, ranging from market developments and the current research landscape of virus-based biopharmaceuticals to industrial-scale study cases for their production and clinical application - always with the patients' view in mind!
It is aimed at researchers, developers and engineers from industry and academia, young scientists, physicians and anyone interested in this rapidly growing therapeutic field.
At the event, we will offer all participants the opportunity for a vivid exchange and networking with speakers and other experts.
We would be pleased to welcome you on November 29th at the “Stadthaus” in Ulm at the Münster Platz and look forward to an inspiring meeting with you!
Uwe Bücheler
(Senior Advisor Biopharmaceuticals, Boehringer Ingelheim; Chairman of the BioPharma Cluster South Germany)
Programm
13:00 - 13:45
Welcome & Keynote
Welcome note
Prof. Dr. Uwe Bücheler
(Chair Biopharma Cluster South Germany)
Prof. Dr. Katharina Hieke-Kubatzky
(Managing director GBM)
Keynote lecture
Dr. Ralf Otto / Dr. Alberto Loche (McKinsey)
Market Trends and Overview (preliminary)
13:45 - 15:15
Perspectives From Academia - Viral Vector Landscape and Biology
Prof. Dr. Frank Kirchhoff (University Ulm, University Hospital Ulm)
Antiviral restriction factors: discovery and relevance
Prof. Dr. Dr. Ulrike Köhl (Fraunhofer IZI Leipzig)
Viral and non-viral gene transfer for manufacturing of CAR effector cells
Prof. Dr. Dr. Guy Ungerechts (Heidelberg University Hospital NCT Heidelberg / DKFZ)
Immunovirotherapy – Clinical Translation
15:15 - 16:15
Networking Coffee & Fingerfood
16:15 - 18:15
Perspectives From Industry - Keynote and Case Studies
Keynote lecture
Prof. Dr. Wolfram Carius (Bayer)
How to navigate an increasing volatile world – Opportunities & Challenges for Cell & Gene Therapy in a Multimodality world
Dr. Jan Schöning (Boehringer Ingelheim)
The Art and Science of Manufacturing Viral Therapeutics
Prof. Dr. Susanne Bailer (Fraunhofer IGB)
A new kid in the BP Cluster South Germany – Setting up the Fraunhofer IGB branch on Virus-based therapeutics VBT in Biberach
Dr. Robert Panting (Rentschler Biopharma)
Optimizing Viral Vector Manufacturing: Balancing Speed and Robustness for Commercial Success
Dr. Kai Lipinski (ReciBioPharm)
Manufacturing of an oncolytic adenovirus first-in-human trials: Challenges and considerations to ensure speed to clinic
18:30 - 19:30
Panel Discussion - Nationale Strategie für Gen- und Zelltherapien
Moderation
Dr. Dorothee Ambrosius (DmA Biotherapeutics Consulting)
Guests
Prof. Dr. Dr. Ulrike Köhl (Universität Leipzig, Fraunhofer IZI)
Prof. Dr. Dr. Guy Ungerechts (Universitätsklinikum Heidelberg, NCT Heidelberg / DKFZ)
Prof. Dr. Wolfram Carius (Bayer)
Prof. Dr. Stephan Stilgenbauer (Universitätsklinikum Ulm, CCCU)
Norman Roßberg (Patientenforschungsrat NCT SüdWest)
19:30 - 20:30
Networking
Registration
Start registration: September 23
Registration fees:
| Students & Members of the GBM |
30 € |
| Academia | 100 € |
| Industry | 300 € |
Information
Accommodation
Participants are expected to book and pay for their own accommodation and travel expenses.
We recommend booking via online portals such as booking.com or hotel.de.
Venue
Stadthaus Ulm
Münsterplatz 50
Office: Münsterplatz 2
89073 Ulm
Organization & Contact
Organizer
BioPharma Cluster
South Germany e.V.
Olgastr. 95-101
89073 Ulm
Phone: +49 731 173225
E-Mail: info@biopharmacluster.com
Meeting Secretariat
Gesellschaft für Biochemie
und Molekularbiologie e.V.
Mörfelder Landstr. 125
60598 Frankfurt am Main
Phone: +49 69 660567-0
E-Mail: info@gbm-online.de